February 28, 2018 / 12:14 PM / 3 months ago

BRIEF-Horizon Pharma PLC Announces Q4 Non-Gaap Earnings Per Share $0.29

Feb 28 (Reuters) - Horizon Pharma Plc:

* ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS

* Q4 NON-GAAP EARNINGS PER SHARE $0.29

* Q4 GAAP LOSS PER SHARE $0.28

* ‍FULL-YEAR 2018 ADJUSTED EBITDA GUIDANCE OF $370 MILLION TO $395 MILLION​

* Q4 EARNINGS PER SHARE VIEW $0.22, REVENUE VIEW $264.5 MILLION — THOMSON REUTERS I/B/E/S

* FY2018 REVENUE VIEW $1.14 BILLION — THOMSON REUTERS I/B/E/S

* HORIZON PHARMA SAYS Q4 NET SALES DRIVEN BY CONTINUED STRONG GROWTH FROM CO’S ORPHAN & RHEUMATOLOGY BUSINESS UNITS​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below